Rexogin (vial) Alpha Pharma




Rexogin (vial) Alpha Pharma: The Ultimate Performance Enhancer for Bodybuilders

Are you ready to take your bodybuilding journey to the next level? Look no further than Rexogin (vial) by Alpha Pharma. This powerful anabolic steroid is designed to help you achieve your fitness goals faster and more efficiently than ever before. With its exceptional quality and proven results, Rexogin is the go-to choice for both beginners and experienced bodybuilders.

Pharmacological Action

Rexogin contains the active ingredient Stanozolol, a synthetic derivative of dihydrotestosterone (DHT). This unique compound enhances protein synthesis and nitrogen retention in the muscles, leading to increased muscle mass, strength, and endurance. It also promotes fat loss by boosting metabolism and reducing water retention, resulting in a leaner and more defined physique.

Specific Details and Features

  • High-Quality Formula: Rexogin is manufactured by Alpha Pharma, a renowned pharmaceutical company known for its commitment to excellence and strict quality control.
  • Purity and Potency: Each vial of Rexogin contains 10ml of Stanozolol with a concentration of 50mg/ml, ensuring optimal effectiveness and reliable results.
  • Easy Administration: Rexogin is designed for intramuscular injection, allowing for precise dosage and rapid absorption into the bloodstream.
  • Long-Lasting Effects: The effects of Rexogin can be felt for up to 48 hours after administration, providing sustained benefits for enhanced performance.
  • Safe and Legal: Rexogin is produced in compliance with international pharmaceutical standards, ensuring its legality and safety for use.

Possible Side Effects

While Rexogin is generally well-tolerated, it’s important to be aware of potential side effects. These may include:

  • Liver Toxicity: Stanozolol is hepatotoxic, so it’s crucial to monitor liver function during its use.
  • Androgenic Effects: Some users may experience acne, oily skin, or accelerated hair loss due to the androgenic properties of Stanozolol.
  • Cardiovascular Risks: Rexogin can negatively impact cholesterol levels, potentially leading to cardiovascular issues. Regular monitoring is advised.

Methods of Use and Dosage

Rexogin is suitable for both male and female bodybuilders, but dosages may vary. It is recommended to start with a low dosage and gradually increase it to assess individual tolerance and response. The typical dosage ranges are as follows:

  • Beginners: 25-50mg every other day for men, and 5-10mg every other day for women.
  • Experienced Bodybuilders: 50-100mg every other day for men, and 10-20mg every other day for women.

It’s important to note that exceeding the recommended dosages can increase the risk of side effects. A cycle of Rexogin usually lasts 6-8 weeks, followed by a post-cycle therapy to restore natural hormone production.

Benefits for Buyers

By choosing Rexogin, you are investing in a product that offers numerous benefits:

  • Accelerated Muscle Growth: Rexogin stimulates protein synthesis, leading to rapid muscle development and increased strength.
  • Enhanced Performance: With improved endurance and stamina, you can push your limits and achieve new personal records.
  • Lean and Defined Physique: Rexogin helps burn excess fat, revealing a chiseled and sculpted body.
  • Improved Recovery: Reduced muscle fatigue and enhanced recovery time allow for more frequent and intense training sessions.
  • Increased Confidence: Achieving your desired physique can boost self-esteem and confidence, both inside and outside the gym.

Don’t settle for mediocrity in your bodybuilding journey. Choose Rexogin (vial) by Alpha Pharma and experience the remarkable transformation that awaits you. Take the leap and unlock your true potential today!

Additional information

substance active


Amount of substance, mg


formulaire de discharge


1 bottle, ml


Packages by package, pcs



Alpha Pharma


There are no reviews yet.

Be the first to review “Rexogin (vial) Alpha Pharma”

Your email address will not be published. Required fields are marked *